Sainte-Catherine Institut du Cancer Avignon-Provence (ICAP)

Avignon 84000

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Metastatic Non Small Cell Lung Cancer

Studies at this site

• Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects — Recruiting now
• Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations — Running, not enrolling